Sarepta Stock Dumps: Pharma Bro Martin Shkreli Still Likes It

benzinga.com/trading-ideas/movers/25/11/48628604/sarepta-stock-dumps-pharma-bro-martin-shkreli-still-likes-it

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stock fell sharply Tuesday following disappointing results from a key clinical trial and ongoing concerns about its drug pipeline. However, "Pharma Bro" Martin Shkreli said he still likes the stock.
SRPT stock is crashing. See the real-time price…

This story appeared on benzinga.com, 2025-11-04 17:11:10.
The Entire Business World on a Single Page. Free to Use →